Empowering People to be Ambassadors of their Own Health Since 1997.


Weekly News

Weekly news updates are currently posted on the Internet site and sent out via e-blast to provide up-to-date information on what has been covered in the news regarding lung cancer in the previous week.  Topics include all stories related to lung cancer as well as personal stories and events.

Week ending May 24, 2015

Roche Receives FDA Approval For Its Cobas KRAS Mutation Test

“Roche recently announced that the United States Food and Drug Administration (FDA) has approved its cobas KRAS Mutation Test to be used for diagnostic purposes.”


Genentech Reveals Encouraging Phase II Clinical Trial Results for Lung Cancer Immunotherapy

“Genentech, a member of the Roche Group focused on cancer immunotherapy and personalized medicine, recently announced interim results of a Phase II study (POPLAR) assessing the investigational cancer immunotherapy MPDL3280A (anti-PDL1) in patients with non-small cell lung cancer (NSCLC).”


California Woman Suffering From Lung Cancer Suing State For Right To Die

“Christy O’Donnell is suffering from Stage IV lung cancer that has spread to her brain, liver, rib and spine, according to USA Today.”


Beebe Auxiliary donates $275,000 to Beebe Healthcare for advanced technology in lung cancer diagnosis

“The Beebe Auxiliary has donated $275,000 to Beebe Healthcare toward the purchase of a navigational bronchoscopy system, an advanced technology that can locate lesions in the far reaches of the lungs where they often go undiagnosed in early stage lung cancer.”


Sarah Cannon Research Institute to Present Cancer Research Insights at American Society of Clinical Oncology’s 51st Annual Meeting

“Research team members to discuss more than 90 presentations related to latest data and innovations for advancing cancer therapies.”


Smoking a significant predictor of lung cancer recurrence in survivors

“In 2015, an estimated 158,040 Americans are expected to die from lung cancer, making it the leading cause of cancer death in in this country. Lung cancer screening with low-dose CT scans in high risk smokers has recently been approved to help detect lung cancer in its early stages when no symptoms are noticeable. The hope is that by detecting lung cancer in the early, more treatable stages, doctors may be able to improve the outcomes of patients with lung cancer. However, in addition to screening high risk smokers, close follow-up and monitoring of lung cancer survivors is also extremely important.”


ASTRO Releases Guidelines for Locally Advanced NSCLC

“New guidelines from the American Society for Radiation Oncology (ASTRO) answer five key questions related to the role of definitive and adjuvant radiation therapy in treating locally advanced non-small cell lung cancer (LA NSCLC).”


Caring Ambassadors Program, Inc. | P.O. Box 1748 | Oregon City, OR 97045 | 503-632-9032 | 503-632-9038 (Fax)